In addition to associations related to the vitamin D receptor gene and BsmI genotypes with glycemic markers, low serum concentrations of 25OHD3 have been associated with reduced insulin sensitivity, impaired glucose metabolism, and metabolic syndrome [53, 54]. Here, INS is linked to metabolic syndrome.